Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Ratings and Reviews 0 Ratings

Total
ease
features
design
support

This software has no reviews. Be the first to write a review.

Write a Review

Alternatives to Consider

  • Stack AI Reviews & Ratings
    20 Ratings
    Company Website
  • PathSolutions TotalView Reviews & Ratings
    42 Ratings
    Company Website
  • RaimaDB Reviews & Ratings
    5 Ratings
    Company Website
  • Windocks Reviews & Ratings
    6 Ratings
    Company Website
  • Google Cloud Platform Reviews & Ratings
    57,010 Ratings
    Company Website
  • TrueCommerce Reviews & Ratings
    924 Ratings
    Company Website
  • Boozang Reviews & Ratings
    15 Ratings
    Company Website
  • D&B Connect Reviews & Ratings
    171 Ratings
    Company Website
  • QVscribe Reviews & Ratings
    1 Rating
    Company Website
  • Epsilon3 Reviews & Ratings
    262 Ratings
    Company Website

What is SpliceCore?

Utilizing RNA sequencing (RNA-seq) data in conjunction with Artificial Intelligence offers both an essential need and a remarkable opportunity for developing therapies that target splicing errors. By harnessing machine learning techniques, we can identify new splicing errors and promptly create therapeutic compounds to rectify these issues. Our specialized AI platform, SpliceCore, is dedicated to the discovery of RNA-based therapeutics. This advanced technology excels in analyzing RNA sequencing data with exceptional speed and accuracy. It effectively identifies, assesses, and confirms potential drug targets, surpassing conventional methods in efficiency. A key feature of SpliceCore is our proprietary database, which houses over 5 million potential RNA splicing errors, making it the largest resource of its type worldwide and vital for evaluating any RNA sequencing dataset submitted for analysis. The incorporation of scalable cloud computing enables us to manage extensive RNA sequencing data efficiently and economically, thereby accelerating the development of new therapies. This groundbreaking strategy is set to transform the field of RNA therapeutics, paving the way for unprecedented advancements in treatment options. As we move forward, the potential for discovery in this domain continues to expand, promising a future filled with innovative solutions.

What is RetinAI?

Healthcare professionals and pharmaceutical companies utilize RetinAI's innovative software platform to efficiently oversee their data while gaining improved insights through automated AI-driven analysis, thus enhancing both clinical practices and research processes. This integrated data solution enables users to retrieve and manage their information from virtually anywhere at any time. It accommodates a wide range of data formats, including both DICOM-compliant and proprietary types. By harnessing the power of AI, data is systematically harmonized, organized, aggregated, and analyzed on a large scale to reveal critical insights regarding disease progression, treatment results, and future disease forecasts. Moreover, the platform promotes collaborative research within organizations by offering secure cloud-based access to essential data. It acts as a central hub for various teams, including data, medical, and digital experts. Users can perform AI-enhanced analyses on their OCT volumes, concentrating on the segmentation of layers and fluids. Quick evaluations can be conducted to gather insights into a single, cohesive platform. Collaborators can be easily invited to engage with datasets while adhering to predefined permission levels, encouraging a more unified research atmosphere. This holistic strategy not only simplifies data management but also significantly boosts collaborative initiatives among diverse teams and disciplines, ultimately leading to more effective outcomes in both research and patient care. Furthermore, the adaptability of the platform ensures it remains relevant as technology and research needs evolve.

Media

Media

Integrations Supported

Additional information not provided

Integrations Supported

Additional information not provided

API Availability

Has API

API Availability

Has API

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Pricing Information

Pricing not provided.
Free Trial Offered?
Free Version

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Supported Platforms

SaaS
Android
iPhone
iPad
Windows
Mac
On-Prem
Chromebook
Linux

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Customer Service / Support

Standard Support
24 Hour Support
Web-Based Support

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Training Options

Documentation Hub
Webinars
Online Training
On-Site Training

Company Facts

Organization Name

Envisagenics

Date Founded

2014

Company Location

United States

Company Website

www.envisagenics.com/platform/

Company Facts

Organization Name

RetinAI

Company Location

Switzerland

Company Website

www.retinai.com

Categories and Features

Categories and Features

Popular Alternatives

Popular Alternatives

BIOiSIM Reviews & Ratings

BIOiSIM

VERISIMLife
BioNeMo Reviews & Ratings

BioNeMo

NVIDIA